
Release date: 2026-01-13 16:59:35 Article From: Lucius Laos Recommended: 203
Capivasertib in combination with Faslodex is indicated for the treatment of adult patients with a specific type of hormone receptor-positive (hormone-dependent, e.g., estrogen-dependent) advanced breast cancer that has spread to adjacent tissues or other parts of the body, and whose disease has progressed during or after certain other therapies.
Capivasertib is also used in combination with another medication plus Faslodex for the treatment of a specific type of hormone receptor-positive advanced breast cancer that has metastasized to other parts of the body, in premenopausal (menopause; cessation of menstruation), perimenopausal and postmenopausal female patients. Capivasertib belongs to the class of medications known as kinase inhibitors. It works by blocking the signal transmission of an abnormal protein that instructs cancer cells to proliferate, thereby helping to slow down or prevent the spread of cancer cells.
Do not consume grapefruit or drink grapefruit juice while taking this medication.
Take the missed dose as soon as you remember it. However, if more than 4 hours have passed since the scheduled time, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.
1. Capivasertib may cause side effects. Tell your doctor if any of the following symptoms are severe or do not go away: nausea, vomiting, mouth ulcers, fatigue, decreased appetite, headache.
2. Some side effects can be serious. Stop taking the medication immediately and call your doctor or seek emergency medical attention if you experience any of the following symptoms or those listed in the Special Precautions section:
3. Skin rash; blistering, peeling, dryness or redness of the skin; blisters on the lips, eyes or mouth; fever; flu-like symptoms
4. Diarrhea (loose, watery stools or increased frequency of bowel movements); stomach cramps
5. Dry mouth, weakness, decreased urine output, swelling of the legs or ankles
6. Frequent urination, painful urination or urgent need to urinate
7. Capivasertib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended:[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended:[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended:[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended:[list:visits]2026-15-07
Regulatory System: From "One Ministry, One Department" to Legal AmendmentsLao drug regulat···【more】
Recommended:[list:visits]2026-14-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643